Using our mobile app? Be sure to check for any new app updates to receive any enhancements.
Logo

Get Healthy!

Results for search "Viruses".

23 Sep

Pregnant Women Who Get COVID Vaccine Pass Antibodies to Newborns

Expectant moms who receive mRNA Covid-19 vaccines pass antibodies to their newborns, researchers find.

Health News Results - 1181

A deal for Merck's COVID-19 pill to be made and sold cheaply in poor nations has been reached with Medicines Patent Pool, a United Nations-backed nonprofit organization.

The royalty-free license means that companies in 105 countries, mostly in Africa and Asia, can sublicense the formulation for the antiviral pill molnupiravir and start making it, the New York Times reported.

<...

WEDNESDAY, Oct. 27, 2021 (HealthDay News) -- Patients suffering from "long COVID" can have symptoms that last a year or more, putting their jobs and everyday routines in jeopardy, a new study finds.

Looking at more than 150 people with long-lasting effects from COVID-19, researchers said the patients reported thinking problems, fatigue, brain fog, headache, sleep proble...

People who've lost their ability to smell and taste due to COVID-19 have significant struggles, but they can find ways to cope with their situation, a new study shows.

One of the most common side effects of COVID-19 is the loss of the sense of smell, which severely affects the sense of taste. This can lead to anxiety, depression and reduced quality of life.

In this study, five women...

It's well-known that COVID-19 pandemic restrictions pretty much quashed the 2020-2021 flu season, with influenza cases falling to never-before-seen lows in the United States.

So little flu circulated, in fact, that some scientists now suspect that one of the major strains of influenza might have gone extinct, for lack of humans to infect.

Influenza B/Yamagata is one of four strains ...

Antibody infusions help keep high-risk COVID-19 patients out of the hospital, but getting the therapy can be a challenge. One U.S. health system has found a creative way to address the problem: home infusions administered by paramedics.

Researchers found that the tactic was feasible, delivering antibody infusions to 144 COVID-19 patients in their homes over three months earlier this year....

Obese people have a tougher time fighting COVID-19, even if they have a milder form of the virus, a new study finds.

Researchers looked at more than 500 patients who tested positive for COVID but didn't require hospitalization. Teens and adults who were overweight or obese had more symptoms, including cough and shortness of breath, than those of normal weight.

"Even when infected wi...

Watch closely if your kids appear to have a common cold this fall or winter. It could instead be respiratory syncytial virus, known as RSV, and that makes it more likely to progress to a serious lower lung infection.

RSV is back in force this year after a reprieve while many stayed home last year because of the COVID-19 pandemic, according to experts at Penn State Health.

"Th...

In some heartening news on the vaccine front, two-thirds of American parents of children ages 5 to 11 plan to get their youngsters vaccinated when COVID-19 shots are approved for that age group, a new survey shows.

"While we're encouraged to see that a majority of parents intend to vaccinate their children against COVID-19 once they are eligible, there is clearly more work to be done to h...

The Moderna and Pfizer COVID vaccines protect against a number of coronavirus variants, including highly contagious Delta, another study confirms.

The findings come as breakthrough infections in vaccinated people raise questions about the vaccines' ability to protect against emerging variants.

The shots do "induce high levels of antibodies against Delta and most variants," said stud...

It could be a bad flu season this year — and for a couple of years to come — in places in the United States where COVID-19 restrictions like social distancing and masking have been lifted, researchers warn.

These sorts of measures caused flu cases to decline by more than 60% within the first 10 weeks after COVID-19 lockdowns were implemented in 2020, Columbia University researchers fo...

Long-term symptoms of coronavirus infection, known as 'long COVID,' affects more than half of COVID-19 survivors, and health care systems should be prepared to treat them, researchers say.

So far, 236 million people worldwide have been diagnosed with COVID-19, and many have had lingering physical and mental health problems for six months or longer.

"The burden of poor health in COV...

THURSDAY, Oct. 14, 2021 (HealthDay News) – From newborns to new adults, young people who get COVID-19 can carry high levels of the virus and spread it to others even if they show no symptoms.

That's the takeaway from a study of 110 people between 2 weeks and 21 years of age who tested positive for SARS-CoV-2 infection.

Researchers found that infants, children and teens were equall...

In a development that could mean Johnson & Johnson might encounter resistance over its application for authorization of a booster shot of its coronavirus vaccine, a new analysis filed by the U.S. Food and Drug Administration on Wednesday suggests the company's evidence may not be strong enough for approval.

A key test used by the company to measure immune response from a booster shot six ...

Merck & Co. announced Monday that it had submitted an application with the U.S. Food and Drug Administration for emergency use approval of the first antiviral pill targeted to COVID-19.

Experts say authorization of molnupiravir, at this time only for use inhigh-risk Americans, could be a major advance in the struggle against COVID-19 because a convenient, more affordable trea...

Experts are warning that the upcoming flu season could be severe as social distancing measures are relaxed across the United States, but a new survey finds that 6 in 10 Americans may delay or skip a flu shot.

However, it also found that 98% of those who got a flu shot last season do plan to get one again this year.

While 82% of the 1,000 adult participants of the online survey sai...

Your chances of getting COVID-19 from surfaces at the grocery store are minimal, a Canadian study reassures.

Researchers at the University of Guelph in Ontario collected 957 samples at four grocery stories over a month. None tested positive for SARS-CoV-2, the virus that causes COVID,

  • Cara Murez
  • |
  • October 12, 2021
  • |
  • Full Page
  • Pfizer Inc. announced Thursday that it has asked the U.S. Food and Drug Administration for emergency approval for its coronavirus vaccine to be given to children between the ages of 5 and 11.

    "We're committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat," the company said in a

    Scientists in Japan have discovered yet another tick-borne virus that can make people sick.

    The Yezo virus is transmitted by tick bites, and triggers fever and a reduction in blood platelets and white blood cells.

    "At least seven people have been infected with this new virus in Japan since 2014, but, so far, no deaths have been confirmed," said Keita Matsuno, a virologist at Hokkaid...

    Since the rise of the Delta variant, one Texas hospital has seen a surge in severe COVID-19 among pregnant women — nearly all unvaccinated.

    Researchers at the Dallas hospital found that in late August and early September, 10% to 15% of pregnant patients who tested positive for COVID-19 needed to be hospitalized for severe illness.

    That was more than double the percentage of a year...

    The ongoing coronavirus pandemic has hit minority groups in the United States hard, with significantly more deaths among Black and Hispanic Americans compared with white and Asian Americans, a new study finds.

    According to the report, these disparities highlight the need to address ongoing inequities influencing health and longevity in the United States.

    What's more, "focusing on CO...

    Booster shots of the Pfizer-BioNTech coronavirus vaccine for people aged 18 and older have been given the green light by the European Medicines Agency.

    They "may be considered at least six months after the second dose for people aged 18 years and older," the European Union's drug regulator said Monday, the Associated Press reported.

    The advice is based on data showing that ...

    People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic.

    At least three contenders are vying to become the first antiviral pill that specifically targets COVID-19, according to reports from drug manufacturers.

    Such a pill could be pr...

    Pharmaceutical giant Merck & Co. said Friday that it will seek federal approval for emergency use of its new antiviral pill molnupiravir, after a clinical trial showed the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection with COVID-19.

    The new medication is just one of several antiviral pills now being tested in studies, and experts s...

    Someday, your smartwatch might be able to tell you if you're coming down with a virus and how sick you'll be — even before symptoms start.

    In a small study, researchers showed that a wearable device, like a Fitbit or Apple Watch, could detect which patients had the H1N1 flu and which had a common cold.

    "One of our goals was to be able to detect that infection before a person feel...

    Artificial intelligence (AI) might be able to spot the next virus to jump from animals to humans, Scottish researchers report.

    Identifying diseases before they become a threat to humans is challenging, because only a few of the nearly 2 million animal viruses can infect humans. By developing machine learning models, researchers can analyze genetic patterns of viruses that might infect peo...

    It seems like common sense for people who've had COVID-19 to think they now have natural immunity, and therefore don't have to bother getting vaccinated.

    Common sense, yes, but also incorrect, infectious disease doctors say.

    Your case of COVID — especially if it was very mild — probably didn't create enough of an immune response to provide lasting protection against SARS-CoV-2, ...

    A new DNA sensor can detect viruses and tell if they are infectious or not in minutes, a new study finds.

    The sensor was developed by using DNA technology, and does not require the need to pretreat test samples. Researchers demonstrated this technique with the human adenovirus (which causes colds and flu) and the virus that causes COVID-19.

    "The infectivity status is very important...

    The future of COVID-19 treatments might include a tiny antibody made by llamas.

    British researchers credit a llama named Fifi with their finding.

    The investigators said these llama nanobodies, which are also produced by camels, could eventually be produced in a lab and administered by a nasal spray, binding tightly to the COVID-19 virus and neutralizing it.

    The potential solu...

    One way to help protect newborns from COVID-19 is for women to get their COVID vaccine while pregnant.

    A new study found that mothers-to-be who had either the Pfizer-BioNTech or Moderna vaccine passed high levels of antibodies to their infants.

    Researchers from the NYU Grossman School of Medicine discovered that 100% of 36 newborns tested at the time of birth had protective antibo...

    Antibodies from current COVID-19 vaccines don't bind well to the new variants of the virus, a study finds.

    Researchers collected data from previously published papers about the sequence of antibodies produced by the vaccines. They focused on antibodies against the spike protein, a part of the virus that binds to receptors on human cells to infect them. It's the target of most vaccines.

    Getting another shot of the Johnson & Johnson COVID-19 vaccine substantially increased its protection, the company announced Tuesday.

    According to the results of a new clinical trial, two doses of the vaccine boosts immunity to 94% from the 74% offered by a single dose, the company said in a statement.

    "Our single-shot vaccine generates strong immune responses and long-lasting immun...

    As the highly contagious Delta variant has swept across the United States, the country has reached a tragic milestone.

    COVID-19 has now killed more Americans than the 1918 Spanish flu pandemic did, when roughly 675,000 people died.

    It didn't have to be that way.

    "Big pockets of American society — and worse, their leaders — have thrown this away" by not getting vaccinated, ...

    If a person is diagnosed with COVID-19 in the United States right now, it's almost certainly caused by the Delta variant.

    The highly transmissible variant, which caused crippling surges in India and Britain this past spring and fueled case spikes in the United States this summer, is now responsible for over 99% of all cases tracked in this country, according to the latest data from the

    A study of millions of people vaccinated against COVID-19 has identified those at greatest risk of hospitalization and death after breakthrough infection.

    The most vulnerable are those who are immunosuppressed from chemotherapy, a recent bone marrow or solid organ transplant, or HIV/AIDS. Also at risk are people with neurological disorders (such as dementia and Parkinson's disease), nur...

    An advisory panel to the U.S. Food and Drug Administration on Friday recommended a third Pfizer-BioNTech COVID vaccine booster shot for all Americans aged 65 or older, as well as for those deemed to be at high risk for severe illness.

    According to The New York Times, that vote came after a near unanimous decision (16 to 2) by the same independent panel of experts that said no to ...

    In kids and teens, symptoms of long COVID rarely last more than 12 weeks, a new international study reports.

    The researchers also found that exposure to the highly contagious Delta variant did not result in more serious disease in children compared to earlier variants, and that most cases of COVID-19 were asymptomatic or mild.

    Despite those reassurances, the study did include a trou...

    U.S. Food and Drug Administration advisors will meet Friday to consider whether it is safe and effective for Americans to receive a third "booster" dose of the Pfizer-BioNTech COVID-19 vaccine.

    The FDA posted the materials it intends to use in the review on Wednesday. The advisory panel will review a variety of evidence, including new data from Israel, the Associated Press repo...

    Health officials are bracing for a viral double whammy this fall and winter.

    "This year, we expect influenza and COVID-19 to circulate at the same time," said Dr. Jonathan Grein, director of hospital epidemiology at Cedars-Sinai in Los Angeles.

    That's why Grein and his colleagues remind Americans that it's time to get your seasonal flu shot. This fall, it's not only a key to keepin...

    As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers.

    Monoclonal antibodies, which are lab-engineered immune system proteins, can help trigger a healthy immune response against COVID-19 infection.

    The Biden administration has also taken over distributing the therapeutics, to help avoid shor...

    If you're making your own face mask to protect against COVID-19, three layers of cotton towel fabric are best, researchers from India report.

    That recommendation comes after testing how best to block cough droplets moving at different rates, from mild to severe.

    "Our results show cotton, towel-based fabrics were most effective among the considered fabrics and must be stitched toget...

    People who eat plenty of fruits and vegetables may have a somewhat lower risk of COVID-19 than those with unhealthy diets, a new study suggests.

    Of more than 590,000 adults surveyed, researchers found that the quarter with the most plant-rich diets had a 9% lower risk of developing COVID-19 than the quarter with the least-healthy diets.

    Their risk of severe COVID-19, meanwhile, was ...

    TUESDAY, Sept. 14, 2021 (HealthDay News) -- New data out of Israel, to be published this week, could bolster the notion that a third booster shot of the COVID-19 vaccine significantly lowers a recipient's odds for severe illness.

    The data is scheduled to be published in the peer-reviewed New England Journal of Medicine, ahead of this week's U.S. Food and Drug Administration advi...

    While in the United States preteens and teens aged 12 to 15 have been eligible for COVID-19 vaccines since the spring, the vaccines are only now becoming available for that age group in the United Kingdom.

    According to the Associated Press,on MondayBritain gave its approval for use of the vaccines in children 12 and older as part of a "tool kit" to avoid lockdowns this fall and ...

    People with HIV have an increased risk of sudden cardiac death, a new study warns, especially if the virus isn't well-controlled.

    Sudden cardiac death occurs when the heart unexpectedly stops beating, usually due to an abrupt electrical malfunction.

    "People living with HIV are already known to have a higher risk of heart attack, stroke, heart failure, blood clots in the lungs and pe...

    Monoclonal antibody infusions can help prevent severe COVID-19, but the best protection is to get vaccinated, experts say.

    Antibodies are made by the immune system to fight infections.

    "The problem is that our immune system takes two to three weeks to make good antibodies," said Dr. Turner Overton, co-director of the Alabama Vaccine Research Clinic at the University of Alabama at Bi...

    A high amount of coronavirus in the lungs is a major contributor to death in COVID-19 patients, new research shows.

    The findings challenge previous theories that simultaneous infections such as pneumonia or an overreaction of the body's immune system are significant factors in COVID-19 deaths, the researchers noted.

    To come to that conclusion, the investigators analyzed bacterial an...

    A common bug called respiratory syncytial virus (RSV) circulating among American kids during what's normally its off-season may cause concern if parents don't know how to tell it apart from COVID-19, experts say.

    Getting RSV during the summer is unusual, but the U.S. Centers for Disease Control and Prevention recently issued an alert about a rise in RSV cases in Southern states.

    "We...

    A drug that lowers cholesterol might help save hospitalized patients with COVID-19, a new, small Israeli study suggests.

    Researchers at Hebrew University of Jerusalem noted that COVID causes a big buildup of cholesterol, which results in inflammation in cells.

    In lab experiments, they found that the cholesterol-lowering drug fenofibrate (TriCor) effectively reduced damage to lung ce...

    New research delivers an answer to a burning question: When are COVID-19 patients most infectious?

    The answer? Two days before and three days after they develop symptoms.

    The findings highlight the importance of rapid testing and quarantine if someone is feeling sick, the study authors said.

    The researchers also found that infected people are more likely to be asymptomatic if ...

    Major pandemics aren't all that rare and they're likely to occur more often in the future, a new study claims.

    "The most important takeaway is that large pandemics like COVID-19 and the Spanish flu are relatively likely," study co-author William Pan said in a news release from Duke University, where he is an associate professor of global environmental health.

    That points to the nee...

    Show All Health News Results